300404 博济医药
已收盘 12-20 15:00:00
资讯
新帖
简况
博济医药（300404）12月10日主力资金净卖出441.34万元
证券之星 · 12-10
博济医药（300404）12月10日主力资金净卖出441.34万元
博济医药（300404）12月9日主力资金净买入1652.21万元
证券之星 · 12-09
博济医药（300404）12月9日主力资金净买入1652.21万元
A股CRO概念股拉升，睿智医药20CM涨停，迦南科技涨近15%，河化股份、德展健康涨停，药明康德涨近8%，药石科技、博济医药、百花医药跟涨。
美港电讯 · 12-09
A股CRO概念股拉升，睿智医药20CM涨停，迦南科技涨近15%，河化股份、德展健康涨停，药明康德涨近8%，药石科技、博济医药、百花医药跟涨。
博济医药新提交1件商标注册申请
证券之星 · 12-06
博济医药新提交1件商标注册申请
博济医药获得发明专利授权：“一种治疗心血管疾病的中药组合物、制备方法及应用”
证券之星 · 11-26
博济医药获得发明专利授权：“一种治疗心血管疾病的中药组合物、制备方法及应用”
博济医药最新公告：公司获得2项发明专利证书
证券之星 · 11-22
博济医药最新公告：公司获得2项发明专利证书
博济医药（300404）11月22日主力资金净卖出1075.13万元
证券之星 · 11-22
博济医药（300404）11月22日主力资金净卖出1075.13万元
博济医药最新公告：公司被认定为国家级专精特新“小巨人”企业
证券之星 · 11-04
博济医药最新公告：公司被认定为国家级专精特新“小巨人”企业
博济医药(300404.SZ)被认定为国家级专精特新“小巨人”企业
智通财经 · 11-04
博济医药(300404.SZ)被认定为国家级专精特新“小巨人”企业
11月1日博济医药发布公告，其股东减持569.2万股
证券之星 · 11-01
11月1日博济医药发布公告，其股东减持569.2万股
博济医药(300404.SZ)股东赵伶俐、费米十三号完成减持 合计减持1.5%股份
智通财经网 · 11-01
博济医药(300404.SZ)股东赵伶俐、费米十三号完成减持 合计减持1.5%股份
博济医药（300404）10月29日主力资金净卖出2667.71万元
证券之星 · 10-29
博济医药（300404）10月29日主力资金净卖出2667.71万元
博济医药：10月27日接受机构调研，华创证券、海通证券等多家机构参与
证券之星 · 10-29
博济医药：10月27日接受机构调研，华创证券、海通证券等多家机构参与
博济医药（300404）2024年三季报简析：营收净利润同比双双增长，公司应收账款体量较大
证券之星 · 10-27
博济医药（300404）2024年三季报简析：营收净利润同比双双增长，公司应收账款体量较大
博济医药(300404)9月30日股东户数2.3万户，较上期减少16.13%
证券之星 · 10-25
博济医药(300404)9月30日股东户数2.3万户，较上期减少16.13%
博济医药(300404.SZ)发布前三季度业绩，净利润4327.78万元，同比增长87.98%
智通财经 · 10-25
博济医药(300404.SZ)发布前三季度业绩，净利润4327.78万元，同比增长87.98%
博济医药最新公告：公司获得发明专利证书
证券之星 · 10-21
博济医药最新公告：公司获得发明专利证书
博济医药（300404）9月20日主力资金净卖出314.45万元
证券之星 · 09-20
博济医药（300404）9月20日主力资金净卖出314.45万元
博济医药（300404）9月10日主力资金净买入70.75万元
证券之星 · 09-10
博济医药（300404）9月10日主力资金净买入70.75万元
博济医药（300404）9月9日主力资金净买入153.36万元
证券之星 · 09-09
博济医药（300404）9月9日主力资金净买入153.36万元
加载更多
公司概况
公司名称：
博济医药科技股份有限公司
所属行业：
研究和试验发展
上市日期：
2015-04-24
主营业务：
博济医药科技股份有限公司主要业务是为国内外制药企业及其他研究机构就新药品、医疗器械的研发与生产提供全流程“一站式”CRO服务。公司主要服务包括临床研究服务、临床前研究服务、CDMO服务、其他咨询服务、临床前自主研发、技术成果转化服务等。作为国内领先的CRO公司，公司在报告期内荣膺“2024中国医药CRO企业20强（排名第8）”“2023年度中国医药研发50强”“持续15年高新技术企业”卓越成就奖等荣誉称号。
发行价格：
12.87
{"stockData":{"symbol":"300404","market":"SZ","secType":"STK","nameCN":"博济医药","latestPrice":9.69,"timestamp":1734678219000,"preClose":9.6,"halted":0,"volume":12416183,"delay":0,"floatShares":276000000,"shares":382000000,"eps":0.1167,"marketStatus":"已收盘","marketStatusCode":5,"change":0.09,"latestTime":"12-20 15:00:00","open":9.63,"high":9.86,"low":9.5,"amount":120000000,"amplitude":0.0375,"askPrice":9.69,"askSize":742,"bidPrice":9.68,"bidSize":543,"shortable":0,"etf":0,"ttmEps":0.1167,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1734917400000},"adr":0,"adjPreClose":9.6,"symbolType":"stock","openAndCloseTimeList":[[1734658200000,1734665400000],[1734670800000,1734678000000]],"highLimit":10.56,"lowLimit":8.64,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":382313813,"pbRate":3.73,"roa":"--","roe":"4.48%","epsLYR":0.0657,"committee":-0.176989,"marketValue":3705000000,"floatMarketCap":2672000000,"peRate":83.033418,"changeRate":0.0094,"turnoverRate":0.045,"status":0},"requestUrl":"/m/hq/s/300404","defaultTab":"news","newsList":[{"id":"2490006375","title":"博济医药（300404）12月10日主力资金净卖出441.34万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2490006375","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490006375?lang=zh_cn&edition=full","pubTime":"2024-12-10 15:31","pubTimestamp":1733815903,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2024年12月10日收盘，博济医药报收于10.16元，下跌1.65%，换手率18.53%，成交量51.11万手，成交额5.34亿元。12月10日的资金流向数据方面，主力资金净流出441.34万元，占总成交额0.83%，游资资金净流入78.36万元，占总成交额0.15%，散户资金净流入362.98万元，占总成交额0.68%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024121000024547.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300404","BK0216"],"gpt_icon":0},{"id":"2490714301","title":"博济医药（300404）12月9日主力资金净买入1652.21万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2490714301","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490714301?lang=zh_cn&edition=full","pubTime":"2024-12-09 15:22","pubTimestamp":1733728924,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2024年12月9日收盘，博济医药报收于10.33元，上涨7.72%，换手率22.55%，成交量62.19万手，成交额6.52亿元。12月9日的资金流向数据方面，主力资金净流入1652.21万元，占总成交额2.53%，游资资金净流入3843.6万元，占总成交额5.9%，散户资金净流出5495.81万元，占总成交额8.43%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024120900013817.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","300404"],"gpt_icon":0},{"id":"2490876245","title":"A股CRO概念股拉升，睿智医药20CM涨停，迦南科技涨近15%，河化股份、德展健康涨停，药明康德涨近8%，药石科技、博济医药、百花医药跟涨。","url":"https://stock-news.laohu8.com/highlight/detail?id=2490876245","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490876245?lang=zh_cn&edition=full","pubTime":"2024-12-09 09:33","pubTimestamp":1733707995,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["LU1997245177.USD","BK0239","BK0251","BK1583","BK0066","300725","BK0132","603259","BK0102","BK0077","LU2125910500.SGD","600721","LU1046422090.SGD","BK1576","BK1141","159982","LU0320764599.SGD","BK0229","LU0708995583.HKD","399300","BK0010","000813","BK0114","300404","LU0456842615.SGD","LU0052750758.USD","BK0216","LU2488822045.USD","02359","BK0071","BK0060","300149","000953","300412","BK0004","BK0028","LU2045819591.USD","LU1997245094.SGD","LU2242644610.SGD"],"gpt_icon":0},{"id":"2489415930","title":"博济医药新提交1件商标注册申请","url":"https://stock-news.laohu8.com/highlight/detail?id=2489415930","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2489415930?lang=zh_cn&edition=full","pubTime":"2024-12-06 05:17","pubTimestamp":1733433437,"startTime":"0","endTime":"0","summary":"证券之星消息，根据企查查数据显示，近日博济医药科技股份有限公司新提交1件商标注册申请。商标申请详情如下：今年以来博济医药科技股份有限公司新申请注册商标17件，截止目前公司共持有注册商标28件，另有50件商标尚在注册申请中。数据来源：企查查以上内容为证券之星据公开信息整理，由智能算法生成，不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024120600004327.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","300404"],"gpt_icon":0},{"id":"2486055911","title":"博济医药获得发明专利授权：“一种治疗心血管疾病的中药组合物、制备方法及应用”","url":"https://stock-news.laohu8.com/highlight/detail?id=2486055911","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486055911?lang=zh_cn&edition=full","pubTime":"2024-11-26 02:16","pubTimestamp":1732558583,"startTime":"0","endTime":"0","summary":"证券之星消息，根据天眼查APP数据显示博济医药新获得一项发明专利授权，专利名为“一种治疗心血管疾病的中药组合物、制备方法及应用”，专利申请号为CN202411261940.6，授权日为2024年11月22日。所述中药组合物包括黄芪、三七、丹参、桃仁、瓜蒌、大黄、菝葜和白子菜。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024112600003264.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300404","BK0216"],"gpt_icon":0},{"id":"2485523948","title":"博济医药最新公告：公司获得2项发明专利证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2485523948","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485523948?lang=zh_cn&edition=full","pubTime":"2024-11-22 17:12","pubTimestamp":1732266746,"startTime":"0","endTime":"0","summary":"博济医药公告，公司近日获得国家知识产权局颁发的2项发明专利证书。其中，“一种治疗心血管疾病的中药组合物、制备方法及应用”属于中医药技术领域，对调血脂、改善血液流变学方面有明显效果；“一种非小细胞肺癌动物模型的构建方法及应用”属于生物医药技术领域，所需肿瘤细胞接种量少，造模周期短，造模成功率高。上述专利的获得对公司经营业绩不会产生重大影响，但有利于公司的技术创新和知识产权保护体系的完善，提升公司核心竞争力。以上内容为证券之星据公开信息整理，由智能算法生成，不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024112200027776.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300404","BK0216"],"gpt_icon":0},{"id":"2485294282","title":"博济医药（300404）11月22日主力资金净卖出1075.13万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2485294282","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485294282?lang=zh_cn&edition=full","pubTime":"2024-11-22 15:32","pubTimestamp":1732260774,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2024年11月22日收盘，博济医药报收于8.69元，下跌6.16%，换手率4.06%，成交量11.19万手，成交额1.0亿元。11月22日的资金流向数据方面，主力资金净流出1075.13万元，占总成交额10.74%，游资资金净流入428.74万元，占总成交额4.28%，散户资金净流入646.39万元，占总成交额6.46%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024112200020177.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300404","BK0216"],"gpt_icon":0},{"id":"2480376696","title":"博济医药最新公告：公司被认定为国家级专精特新“小巨人”企业","url":"https://stock-news.laohu8.com/highlight/detail?id=2480376696","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480376696?lang=zh_cn&edition=full","pubTime":"2024-11-04 16:49","pubTimestamp":1730710141,"startTime":"0","endTime":"0","summary":"博济医药公告，公司近日收到工业和信息化部颁发的专精特新“小巨人”企业证书，有效期为3年。公司被认定为专精特新“小巨人”企业，体现了公司在技术创新、产品服务及未来发展前景等方面得到了有关政府部门的充分认可及高度肯定，有利于提高公司的品牌知名度，进一步提升公司的核心竞争力和行业影响力，对公司未来业务的整体发展产生积极影响。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024110400021074.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","300404"],"gpt_icon":0},{"id":"2480789263","title":"博济医药(300404.SZ)被认定为国家级专精特新“小巨人”企业","url":"https://stock-news.laohu8.com/highlight/detail?id=2480789263","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480789263?lang=zh_cn&edition=full","pubTime":"2024-11-04 16:02","pubTimestamp":1730707366,"startTime":"0","endTime":"0","summary":"智通财经APP讯，博济医药(300404.SZ)发布公告，近日，公司收到工业和信息化部颁发的专精特新“小巨人”企业证书，本次专精特新“小巨人”企业的有效期为3年(2024年7月1日-2027年6月30日)。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1206244.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0216","300404"],"gpt_icon":0},{"id":"2480883929","title":"11月1日博济医药发布公告，其股东减持569.2万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2480883929","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480883929?lang=zh_cn&edition=full","pubTime":"2024-11-01 21:00","pubTimestamp":1730466057,"startTime":"0","endTime":"0","summary":"证券之星消息，11月1日博济医药发布公告《博济医药:关于控股股东的一致行动人减持计划期限届满暨实施完毕的公告》，其股东横琴广金美好基金管理有限公司-广金美好费米十三号私募证券投资基金、赵伶俐于2024年8月6日至2024年10月30日间合计减持569.2万股，占公司目前总股本的1.4892%，变动期间该股股价上涨21.56%，截止10月30日收盘报9.19元。股东增减持详情见下表：根据博济医药2024年中报公布的十大股东详情如下：以上内容为证券之星据公开信息整理，由智能算法生成，不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024110100045902.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300404","BK0216"],"gpt_icon":0},{"id":"2480600780","title":"博济医药(300404.SZ)股东赵伶俐、费米十三号完成减持 合计减持1.5%股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2480600780","media":"智通财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480600780?lang=zh_cn&edition=full","pubTime":"2024-11-01 20:15","pubTimestamp":1730463303,"startTime":"0","endTime":"0","summary":"智通财经APP讯，博济医药(300404.SZ)公告，公司收到控股股东、实际控制人王廷春先生的一致行动人赵伶俐女士、费米十三号出具的《关于股份减持计划实施完毕的告知函》，赵伶俐女士通过大宗交易减持公司股票共计189.7万股，占公司总股本的0.50%;费米十三号通过集中竞价减持公司股票共计379.5万股，占公司总股本的1.00%。更多港股重磅资讯，下载智通财经app更多港股及海外理财资讯，请点击www.zhitongcaijing.com（搜索“智通财经”）；欲加入智通港股投资群，请加智通客服微信(ztcjkf)","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1205876.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["300404","BK0216"],"gpt_icon":0},{"id":"2479284774","title":"博济医药（300404）10月29日主力资金净卖出2667.71万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2479284774","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479284774?lang=zh_cn&edition=full","pubTime":"2024-10-29 15:26","pubTimestamp":1730186801,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2024年10月29日收盘，博济医药报收于9.29元，下跌5.88%，换手率8.08%，成交量22.27万手，成交额2.12亿元。10月29日的资金流向数据方面，主力资金净流出2667.71万元，占总成交额12.61%，游资资金净流入728.2万元，占总成交额3.44%，散户资金净流入1939.51万元，占总成交额9.17%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024102900021241.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","300404"],"gpt_icon":0},{"id":"2479495932","title":"博济医药：10月27日接受机构调研，华创证券、海通证券等多家机构参与","url":"https://stock-news.laohu8.com/highlight/detail?id=2479495932","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479495932?lang=zh_cn&edition=full","pubTime":"2024-10-29 08:42","pubTimestamp":1730162543,"startTime":"0","endTime":"0","summary":"证券之星消息，2024年10月28日博济医药发布公告称公司于2024年10月27日接受机构调研，华创证券、海通证券、华鑫证券、国联证券、中邮证券、中泰证券、中原证券、信达证券、富国基金、平安资管、长盛基金、招商证券、东方资管、德邦基金、华宝基金、中金公司、中信资管、国泰基金、华夏基金、博时基金、中欧基金、申万宏源、太平洋证券、华安证券、东北证券、光大证券、开源证券、银河证券参与。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024102900008790.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0183","600837","161027","BK0028","BK1564","BK0216","BK0188","BK0012","BK0070","300404","06837","BK0276","BK1147"],"gpt_icon":0},{"id":"2478184336","title":"博济医药（300404）2024年三季报简析：营收净利润同比双双增长，公司应收账款体量较大","url":"https://stock-news.laohu8.com/highlight/detail?id=2478184336","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478184336?lang=zh_cn&edition=full","pubTime":"2024-10-27 10:59","pubTimestamp":1729997952,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理，近期博济医药发布2024年三季报。截至本报告期末，公司营业总收入5.56亿元，同比上升55.01%，归母净利润4327.78万元，同比上升87.98%。本报告期博济医药公司应收账款体量较大，当期应收账款占最新年报归母净利润比达687.92%。去年的净利率为4.89%，算上全部成本后，公司产品或服务的附加值不高。2024 年半年度，公司新增临床研究服务合同额 7.19 亿元，同比增长 60.99%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024102700011357.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300404"],"gpt_icon":0},{"id":"2478466603","title":"博济医药(300404)9月30日股东户数2.3万户，较上期减少16.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2478466603","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478466603?lang=zh_cn&edition=full","pubTime":"2024-10-25 17:11","pubTimestamp":1729847478,"startTime":"0","endTime":"0","summary":"证券之星消息，近日博济医药披露，截至2024年9月30日公司股东户数为2.3万户，较6月30日减少4424.0户，减幅为16.13%。在医疗服务行业个股中，博济医药股东户数低于行业平均水平，截至9月30日，医疗服务行业平均股东户数为4.48万户。从股价来看，2024年6月30日至2024年9月30日，博济医药区间涨幅为11.86%，在此期间股东户数减少4424.0户，减幅为16.13%。以上内容为证券之星据公开信息整理，由智能算法生成，不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024102500030171.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300404","BK0216"],"gpt_icon":0},{"id":"2478672800","title":"博济医药(300404.SZ)发布前三季度业绩，净利润4327.78万元，同比增长87.98%","url":"https://stock-news.laohu8.com/highlight/detail?id=2478672800","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478672800?lang=zh_cn&edition=full","pubTime":"2024-10-25 16:11","pubTimestamp":1729843904,"startTime":"0","endTime":"0","summary":"智通财经APP讯，博济医药(300404.SZ)发布2024年第三季度报告，公司前三季度营业收入5.56亿元，同比增长55.01%;归属于上市公司股东的净利润4327.78万元，同比增长87.98%;归属于上市公司股东的扣除非经常性损益的净利润3488.98万元，同比增长155.65%;基本每股收益0.1133元/股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1199712.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["300404"],"gpt_icon":0},{"id":"2477835174","title":"博济医药最新公告：公司获得发明专利证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2477835174","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477835174?lang=zh_cn&edition=full","pubTime":"2024-10-21 16:52","pubTimestamp":1729500767,"startTime":"0","endTime":"0","summary":"博济医药公告，公司近日获得国家知识产权局颁发的一项发明专利证书，发明名称：一种祛风除湿消炎止痛的中药组合物及其制备方法和应用。以上内容为证券之星据公开信息整理，由智能算法生成，不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024102100020184.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300404","BK0216"],"gpt_icon":0},{"id":"2468694159","title":"博济医药（300404）9月20日主力资金净卖出314.45万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2468694159","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2468694159?lang=zh_cn&edition=full","pubTime":"2024-09-20 15:23","pubTimestamp":1726817011,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2024年9月20日收盘，博济医药报收于7.05元，下跌2.49%，换手率1.94%，成交量5.34万手，成交额3783.68万元。9月20日的资金流向数据方面，主力资金净流出314.45万元，占总成交额8.31%，游资资金净流入82.41万元，占总成交额2.18%，散户资金净流入232.04万元，占总成交额6.13%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024092000016915.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","300404"],"gpt_icon":0},{"id":"2466078171","title":"博济医药（300404）9月10日主力资金净买入70.75万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2466078171","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2466078171?lang=zh_cn&edition=full","pubTime":"2024-09-10 15:23","pubTimestamp":1725953009,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2024年9月10日收盘，博济医药报收于7.29元，下跌2.28%，换手率2.99%，成交量8.25万手，成交额6022.51万元。9月10日的资金流向数据方面，主力资金净流入70.75万元，占总成交额1.17%，游资资金净流入434.06万元，占总成交额7.21%，散户资金净流出504.8万元，占总成交额8.38%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024091000018628.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300404","BK0216"],"gpt_icon":0},{"id":"2466770134","title":"博济医药（300404）9月9日主力资金净买入153.36万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2466770134","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2466770134?lang=zh_cn&edition=full","pubTime":"2024-09-09 15:21","pubTimestamp":1725866508,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2024年9月9日收盘，博济医药报收于7.46元，上涨3.18%，换手率3.26%，成交量8.98万手，成交额6650.47万元。9月9日的资金流向数据方面，主力资金净流入153.36万元，占总成交额2.31%，游资资金净流入128.12万元，占总成交额1.93%，散户资金净流出281.48万元，占总成交额4.23%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024090900013670.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300404","BK0216"],"gpt_icon":0}],"profile":{"ret":0,"listingDate":"2015-04-24","address":"广东省广州市黄埔区科学城南翔一路62号(二,三,四,五)栋","stockEarnings":[{"period":"1week","weight":-0.0142},{"period":"1month","weight":0.0342},{"period":"3month","weight":0.3745},{"period":"6month","weight":0.1919},{"period":"1year","weight":0.0745},{"period":"ytd","weight":0.0841}],"companyName":"博济医药科技股份有限公司","boardCode":"AI0073","perCapita":"11992股","boardName":"研究和试验发展","registeredCapital":"38231万元","compareEarnings":[{"period":"1week","weight":-0.007},{"period":"1month","weight":0},{"period":"3month","weight":0.2307},{"period":"6month","weight":0.1234},{"period":"1year","weight":0.154},{"period":"ytd","weight":0.1321}],"survey":" 博济医药科技股份有限公司主要业务是为国内外制药企业及其他研究机构就新药品、医疗器械的研发与生产提供全流程“一站式”CRO服务。公司主要服务包括临床研究服务、临床前研究服务、CDMO服务、其他咨询服务、临床前自主研发、技术成果转化服务等。作为国内领先的CRO公司，公司在报告期内荣膺“2024中国医药CRO企业20强（排名第8）”“2023年度中国医药研发50强”“持续15年高新技术企业”卓越成就奖等荣誉称号。","serverTime":1734770598376,"listedPrice":12.87,"stockholders":"22995人(较上一季度减少16.13%)","compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"博济医药(300404)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供博济医药(300404)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"博济医药,300404,博济医药股票,博济医药股票老虎,博济医药股票老虎国际,博济医药行情,博济医药股票行情,博济医药股价,博济医药股市,博济医药股票价格,博济医药股票交易,博济医药股票购买,博济医药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"博济医药(300404)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供博济医药(300404)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}